SCHEMBL17807281

SCHEMBL17807281

c1ccc2c(c1)oc1c2ccc2c1c1ccccc1n2-c1ccc2oc3cc4oc5ccc(-n6c7ccccc7c7c8oc9ccccc9c8ccc76)cc5c4cc3c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.37
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
MAPT P10636 5/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 3/20 0.37
AHR P35869 3/20 0.37
NPC1 O15118 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
RAB9A P51151 2/20 0.37
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GAA P10253 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CYP3A4 P08684 1/20 0.33
ALPI P09923 1/20 0.33
PKM P14618 1/20 0.33
CASP3 P42574 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17807299 0.98 MAOA (0.36) MAOAMEN1KMT2AMAPTKDM4E
SCHEMBL17807280 0.96 MEN1 (0.38) MAOAMEN1KMT2AMAPTKDM4E
SCHEMBL17246134 0.96 MAPT (0.40) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL9890026 0.96 MAPT (0.40) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL24805798 0.95 MEN1 (0.37) MAOAMEN1KMT2AMAPTKDM4E
SCHEMBL17807308 0.94 MAPT (0.38) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL17807276 0.94 MAPT (0.38) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL17807292 0.94 MAPT (0.38) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL17807278 0.94 ALDH1A1 (0.36) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL16484590 0.94 MEN1 (0.40) MAOAMEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160163996-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed
US-20160163996-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160163996-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME LEF1, PIEZO1, EPCAM MAOA 963/4885MEN1 314/4885KMT2A 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.